J parathyr dis. 2018;6(2): 36-38.
doi: 10.15171/jpd.2018.14
  Abstract View: 2376
  PDF Download: 840


The need for a reliable bone biomarker to better assess chronic kidney disease mineral and bone disorder

Ramin Tolouian 1*, Ajay Gupta 2

1 Department of Internal Medicine, Manatee Memorial Hospital, Bradenton, FL, USA.
2 Rockwell Medical, Wixom, MI, USA.
*Corresponding author: Ramin Tolouian, Tolouian@yahoo.com


Chronic kidney disease mineral and bone disorder is a metabolic bone disease present in almost all uremic patients. There are no good markers of bone resorption available for uremic patients. The validity of parathormone as a surrogate marker of bone and mineral disorders has been questioned over the past decade. We need to shift from Surrogate markers to bone markers.
Keywords: Chronic kidney disease, Mineral and bone disorder, Renal osteodystrophy, Parathyroid hormone, End- stage renal disease, Hypoparathyroidism
First Name
Last Name
Email Address
Security code

Abstract View: 2376

Your browser does not support the canvas element.

PDF Download: 840

Your browser does not support the canvas element.

ePublished: 25 Sep 2017
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)